; (B) broadening the awareness of the public concerning— (i) the risk factors for and the symptoms of DVT/PE; (ii) target populations with greater risk for DVT/PE, including women, seniors, cancer patients, hospitalized patients, pregnant and postpartum women, Black Americans, and those in rural areas; and (iii) the public health consequences of DVT/PE; and (C) increasing screening, detection, and diagnosis of DVT/PE; and (2) surveillance of the prevalence and incidence of DVT/PE to improve patient outcomes. (c) Grant and contract prioritization The Secretary may, in awarding grants or entering into contracts under this section, give priority to entities seeking to carry out projects that target the populations referred to in subsection (b)(1)(B)(ii). (d) Coordination of activities The Secretary shall ensure that projects carried out under this section are coordinated, as appropriate, with other agencies of the Public Health Service that carry out activities regarding DVT/PE. (e) Best practices The Secretary shall— (1) collect and analyze the findings of research conducted with respect to DVT/PE; and (2) taking into account such findings, publish on the website of the Centers for Disease Control and Prevention best practices for physicians and other health care providers who provide care to individuals with DVT/PE. . 4. Advisory Committee for DVT/PE Prevention (a) Establishment Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the Secretary ) shall establish an advisory committee to be known as the Advisory Committee for DVT/PE Prevention (in this section referred to as the Advisory Committee ). (b) Duties The Advisory Committee shall— (1) identify the aggregate number of individuals in the United States who experience DVT/PE annually; (2) identify how data are collected regarding DVT/PE and the adverse outcomes associated with such conditions; (3) identify how DVT/PE impacts the lives of individuals in the United States